Spero Therapeutics Inc. (SPRO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.92
-0.05 (-5.56%)
At close: Jan 15, 2025, 10:26 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | 22.81M | -46.41M | -89.76M | -78.28M | -60.92M | -41.66M | -39.89M | -32.64M | -13.15M |
Depreciation & Amortization | 367.00K | 869.00K | 646.00K | 761.00K | 750.00K | 409.00K | 363.00K | 279.00K | 11.00K |
Stock-Based Compensation | 7.93M | 9.12M | 9.43M | 4.89M | 3.78M | 2.75M | 1.43M | 180.00K | 21.00K |
Other Working Capital | -71.14M | 22.57M | 12.95M | -10.42M | 6.27M | -1.16M | -1.91M | -148.00K | -501.00K |
Other Non-Cash Items | 6.28M | 6.61M | 2.37M | 513.00K | 356.00K | -50.00K | -1.54M | 4.59M | 3.52M |
Deferred Income Tax | n/a | n/a | 60.00K | -362.00K | -808.00K | n/a | 83.00K | -580.00K | -174.00K |
Change in Working Capital | -70.38M | 22.09M | 12.90M | -13.39M | 6.83M | -1.07M | 443.00K | -792.00K | 170.00K |
Operating Cash Flow | -32.99M | -7.73M | -64.35M | -85.87M | -50.02M | -39.63M | -39.11M | -28.96M | -9.61M |
Capital Expenditures | n/a | n/a | 39.00K | -157.00K | -314.00K | -2.44M | -27.00K | -830.00K | -232.00K |
Acquisitions | n/a | n/a | -39.00K | -10.63M | -29.84M | 83.16M | -1.18M | n/a | n/a |
Purchase of Investments | n/a | -26.97M | -43.91M | -45.72M | -88.99M | -130.18M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 60.78M | 51.55M | 56.35M | 118.84M | 49.45M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 33.81M | 39.00K | 10.63M | 29.84M | -83.16M | -27.00K | n/a | n/a |
Investing Cash Flow | n/a | 33.81M | 7.67M | 10.47M | 29.53M | -83.16M | -27.00K | -830.00K | -232.00K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -54.06M | 48.68M | 52.22M | 350.00K | -977.00K | 38.36M | 34.41M | 15.28M |
Financial Cash Flow | 221.00K | -29.55M | 84.05M | 130.88M | 16.14M | 69.52M | 116.11M | 34.41M | 15.28M |
Net Cash Flow | -32.77M | -3.48M | 27.38M | 55.48M | -4.35M | -53.26M | 76.97M | 4.62M | 5.43M |
Free Cash Flow | -32.99M | -7.73M | -64.31M | -86.03M | -50.33M | -42.06M | -39.14M | -29.79M | -9.84M |